Eton Pharmaceuticals (ETON) Financials

$59.35

$0.90 (1.53%)

As on 08-Sep-2026 16:13EDT

Market cap

$1,671 Mln

Revenue (TTM)

$106 Mln

P/E Ratio

149.9

P/B Ratio

36.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	105.60	79.95	39.01	31.64	21.25	21.83
Cost of Revenue	44.49	37.21	15.60	10.58	6.93	2.62
Gross Profit	61.10	42.74	23.41	21.06	14.32	19.21
Operating Expenses	44.79	42.67	26.01	22.25	22.58	20.70
Operating Profit (EBIT)	16.31	0.07	-2.60	-1.19	-8.26	-1.50
Other Income	--	--	--	--	-0.76	--
Profit before Tax	12.75	-4.56	-3.81	-0.69	-9.02	-1.96
Provision for Tax	0.06	0.04	0.02	0.25	0.76	1.01
Profit after Tax (Net Income)	12.69	-4.60	-3.82	-0.94	-9.02	-1.96
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-9.02	-1.96

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	46.59	26.15	24.43	15.48	13.08	17.63
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	24.10	27.47	31.75	0.02	5.49	5.28
Current Liabilities	45.12	38.49	19.95	16.24	6.46	4.56
Total Liabilities	160.93	92.11	76.12	31.74	25.03	27.47

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	47.21	31.53	35.10	4.90	5.03	3.86
Current Assets	68.60	60.58	41.02	26.84	20.00	23.60
Total Assets	160.93	92.11	76.12	31.74	25.03	27.47
Total Debt*	28.99	31.02	29.99	5.40	6.52	6.70
Net Current Assets	23.48	22.09	21.07	10.60	13.54	19.05

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	10.52	0.97	6.82	4.82	-4.72
Cash Flow from Investing Activities	--	-0.33	-40.01	-0.78	-2.79	-2.56
Cash from Financing Activities	--	0.82	32.59	-0.96	-0.13	0.39
Net Cash Inflow / Outflow	--	--	--	--	1.90	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.39	-0.17	-0.15	-0.04	-0.35	-0.08
Cash EPS ($)	--	-0.02	-0.10	0.00	-0.28	-0.06
Adjusted Book Value ($)	--	0.97	0.93	0.60	0.51	0.68
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.39	0.04	0.26	0.19	-0.18
Free Cash Flow per Share ($)	--	0.38	0.04	0.23	0.08	-0.31

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-8.25	-10.15	-4.62	-41.07	-8.30
ROE (%)	34.89	-18.19	-19.16	-6.56	-58.75	-11.74
ROA (%)	8.42	-5.47	-7.09	-3.30	-34.37	-7.27
EBIT Margin (%)	2.47	0.28	-4.62	-2.18	-42.45	-8.95
Net Margin (%)	12.02	-5.75	-9.80	-2.96	-44.03	-8.95
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	81.49	1.05	0.23	0.49	-0.03	558.79
EBIT Growth (%)	257.60	112.37	-161.68	92.36	-361.43	92.79
Net Profit Growth (%)	407.36	-20.35	-308.44	89.62	-361.43	93.01
EPS Growth (%)	350.79	-0.17	-3.02	0.90	-3.66	0.94
Book Value Growth (%)	59.47	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	149.87	-98.89	-91.06	-120.45	-8.03	-56.96
Price / Book Value	36.80	17.40	14.25	7.28	5.54	6.32
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	82.32	107.83	-552.80	456.41	-8.65	-69.42
Close Price ($)	36.20	16.91	13.32	4.38	2.82	4.29
High Price ($)	37.49	23.00	13.98	5.81	4.78	10.30
Low Price ($)	13.51	11.09	3.03	2.42	1.95	3.54
Market Cap ($ Cr)	1,670.68	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.41	1.19	1.23	0.35	0.50	0.38
Short term debt to equity ratio	0.19	0.34	0.00	0.35	0.08	0.08
Current Ratio	1.52	1.57	2.06	1.65	3.10	5.18
Quick Ratio	1.30	1.17	1.29	1.60	3.01	5.06
Interest Coverage	3.94	0.05	-0.90	-0.65	-9.45	-1.88

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	23.57	14.71	13.74	10.78	8.71	25.06
Asset Turnover	0.70	0.95	0.72	1.11	0.81	0.81
Receivable days	--	39.10	41.06	30.38	62.93	46.17
Inventory Days	--	150.43	188.98	25.34	29.16	124.77
Payable days	--	74.32	70.42	62.38	93.25	286.71
Cash Conversion Cycle	--	115.21	159.63	-6.66	-1.16	-115.78

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.